Is the US prepared to deal with another pandemic or widespread health crisis?
I will assess US pandemic preparedness based on recent official reports, expert analyses, and data on key capacities (surveillance, stockpiles, healthcare surge, funding, and lessons from COVID-19).No, the US is not fully prepared for another pandemic or widespread health crisis, though it is stronger in some technical areas than before COVID-19. Progress has been made in surveillance, certain stockpiles, and coordination structures, but major gaps remain in leadership, sustained funding, public health infrastructure, medical countermeasures (MCMs), healthcare surge capacity, supply chains, and equitable state/local readiness. Expert assessments, including from bipartisan commissions, GAO, and others, consistently describe preparedness as incomplete, fragile, or “dangerously vulnerable,” with recent funding and workforce disruptions adding further risks.[1][2]
Areas of Progress
Post-COVID investments and reforms have yielded tangible improvements:
FEMA’s National Preparedness Reports note pandemics as a top stressing hazard, with communities identifying related capability gaps, but federal tools have matured.[7]
Persistent and Emerging Gaps
Independent reviews paint a more sobering picture:
GAO, HHS OIG, Stimson Center, TFAH (“Ready or Not” series), and Johns Hopkins analyses reinforce these points: progress is real but incomplete, and backsliding risks are high without sustained political will and resources.[2]
Bottom Line and Outlook
The US can detect and initially respond better than in early 2020 for many scenarios, thanks to data upgrades, stocked PPE/ventilators in key categories, and institutional memory. However, it is not adequately prepared for a high-consequence event (novel respiratory pathogen with high transmissibility/severity, engineered threat, or cascading multi-hazard crisis). A severe pandemic would still likely overwhelm parts of the healthcare system, expose supply/equity gaps, and face coordination/trust hurdles. Current threats like avian influenza underscore ongoing risks.
Preparedness is a continuous process requiring stable multi-year funding, bipartisan leadership, SLTT strengthening, domestic manufacturing resilience, MCM R&D (including platform technologies), workforce rebuilding, and exercises that close gaps. Without reversing recent disruptions and fully implementing recommendations from the Bipartisan Commission, GAO, and others, vulnerability will persist or grow. Assessments evolve with policy, budgets, and emerging science—monitoring official sources (CDC, ASPR, GAO, WHO JEE follow-ups) is essential.
Citations (12)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Expert assessments, including from bipartisan commissions, GAO, and others, consistently describe preparedness as incomplete, fragile, or “dangerously vulnerable,” with recent funding and workforce disruptions adding further risks.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Expert assessments, including from bipartisan commissions, GAO, and others, consistently describe preparedness as incomplete, fragile, or “dangerously vulnerable,” with recent funding and workforce disruptions adding further risks.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC has advanced forecasting/modeling via its Center for Forecasting and Outbreak Analytics, wastewater monitoring, and platforms for real-time data sharing (e.g., “One CDC” Data Platform).”
- https://politifact.com/truth-o-meter/promises/biden-promise-tracker/promise/387091/rebuild-health-stockpiles-be-ready-crises/article/387095/
Backs: “It has supported responses to mpox (over 1 million JYNNEOS vials and tens of thousands of treatment courses) and H5N1 (PPE and antivirals). Domestic manufacturing efforts and Defense Production Act use have aimed to reduce foreign dependence.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “The US completed a 2024 Joint External Evaluation (JEE) of IHR capacities (using a post-COVID tool), with relatively strong scores in areas like laboratory systems, surveillance, emergency response operations, and some immunization/response metrics (though full detailed scores and recommendations highlight needs for…”
- https://iris.who.int/bitstream/handle/10665/380155/9789240105409-eng.pdf?sequence=1sask
Backs: “The US completed a 2024 Joint External Evaluation (JEE) of IHR capacities (using a post-COVID tool), with relatively strong scores in areas like laboratory systems, surveillance, emergency response operations, and some immunization/response metrics (though full detailed scores and recommendations highlight needs for…”
- https://www.fema.gov/sites/default/files/documents/fema_2023-npr.pdf
Backs: “Investments in platforms (e.g., mRNA historically) and BARDA/ASPR efforts continue for select threats. FEMA’s National Preparedness Reports note pandemics as a top stressing hazard, with communities identifying related capability gaps, but federal tools have matured.”
- https://www.gao.gov/products/gao-24-106260
Backs: “SNS coordination with jurisdictions has faced ongoing issues (outdated guidance, unclear roles).”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “Recent years (2025–2026 data) show CDC workforce reductions (reports of ~25–30% declines in some periods), grant terminations/clawbacks (billions), proposed or enacted cuts to preparedness programs, mRNA/vaccine R&D wind-downs in some areas, and global health security disruptions.”
- https://www.tfah.org/article/new-report-chronic-underinvestment-and-recent-disruptions-have-weakened-u-s-public-health-system/
Backs: “Recent years (2025–2026 data) show CDC workforce reductions (reports of ~25–30% declines in some periods), grant terminations/clawbacks (billions), proposed or enacted cuts to preparedness programs, mRNA/vaccine R&D wind-downs in some areas, and global health secur”
- https://www.nationalacademies.org/news/action-needed-to-improve-u-s-smallpox-readiness-and-diagnostics-vaccines-and-therapeutics-says-new-report
Backs: “BioWatch (air detection) is widely criticized as ineffective. Rapid at-scale diagnostics and novel platforms lag. Healthcare system surge capacity, pediatric planning, and workforce (nurses, labs, etc.) have shortfalls.”
- https://www.homelandsecuritynewswire.com/dr20230424-pandemic-preparedness-policy
Backs: “Rapid at-scale diagnostics and novel platforms lag. Healthcare system surge capacity, pediatric planning, and w”